×
About 10,465 results

ALLMedicine™ Urticaria Center

Research & Reviews  2,453 results

Clinical observation and analysis of skin reactions caused by COVID-19 vaccination.
https://doi.org/10.1111/dth.15746
Dermatologic Therapy; Li Y, Fan L et. al.

Oct 4th, 2022 - The novel coronavirus disease 2019 (COVID-19) vaccination is now an essential strategy for controlling the COVID-19 epidemic. This study included 132 cases of adverse skin reactions after the injection of COVID-19 vaccination from January 2021 to ...

Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic ...
https://doi.org/10.1111/dth.15747
Dermatologic Therapy; Shreberk-Hassidim R, Aizenbud L et. al.

Oct 4th, 2022 - Melanoma is widely treated with programmed cell death-1 (PD-1) inhibitors. As part of their anti-tumor immunity effect, they increase the susceptibility to cutaneous immune-related adverse events (cIRAE) among other autoimmune effects. To characte...

Clinical and laboratory parameters associated with treatment response to third-line the...
https://doi.org/10.1111/dth.15887
Dermatologic Therapy; Mehta H, Bishnoi A et. al.

Oct 2nd, 2022 - Current guidelines recommend omalizumab and cyclosporine for management of chronic spontaneous urticaria (CSU) refractory to anti-histamines. Identification of clinico-epidemiological characteristics predictive of treatment response with both moda...

Novel biologics for treatment of chronic spontaneous urticaria.
https://doi.org/10.1016/j.jaci.2022.06.027
The Journal of Allergy and Clinical Immunology; Casale TB

Oct 1st, 2022 - Chronic idiopathic/spontaneous urticaria (CIU/CSU) causes significant impairments in quality of life and is often unresponsive to antihistamines. Although the anti-IgE mAb omalizumab has been an important addition to the therapeutic armamentarium ...

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)
https://clinicaltrials.gov/ct2/show/NCT04612725

Sep 30th, 2022 - The aim of this study is to investigate the use of benralizumab as treatment for patients with chronic spontaneous urticaria (CSU) who are symptomatic despite the use of antihistamines. It is proposed that benralizumab will deplete eosinophils and...

see more →

Guidelines  7 results

The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why
https://pubmed.ncbi.nlm.nih.gov/33857657/
The Journal of Allergy and Clinical Immunology; Metz M

Jun 3rd, 2021 - In chronic spontaneous urticaria (CSU), the guidelines recommend very limited diagnostic procedures during the routine workup, although additional investigations might be indicated in some patients with CSU. For physicians treating patients with C...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

see more →

Drugs  1,071 results see all →

Clinicaltrials.gov  247 results

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)
https://clinicaltrials.gov/ct2/show/NCT04612725

Sep 30th, 2022 - The aim of this study is to investigate the use of benralizumab as treatment for patients with chronic spontaneous urticaria (CSU) who are symptomatic despite the use of antihistamines. It is proposed that benralizumab will deplete eosinophils and...

Pathogenesis of Physical Induced Urticarial Syndromes
https://clinicaltrials.gov/ct2/show/NCT00887939

Sep 30th, 2022 - Urticaria is a common skin disorder that is classified according to its chronicity into acute and chronic forms. It may occur spontaneously or on exposure to a physical factor. In the latter case, the urticaria is classified as a physical urticari...

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03770273

Sep 29th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Quality of Life and Eating Disorders in Children With FPIES, Food Allergy or Celiac Disease
https://clinicaltrials.gov/ct2/show/NCT04643704

Sep 28th, 2022 - 1.1 Current state of knowledge IgE-mediated food allergies are allergies whose symptoms are urticaria, angioedema, rhinoconjunctivitis, digestive signs, bronchospasm, or even anaphylaxis within 2 hours after ingestion of food. The prevalence of th...

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03401060

Sep 27th, 2022 - Systemic mastocytosis (SM) represents a heterogenous group of disease characterized by abnormal proliferation of mast cells caused by activating mutations in c-Kit receptor; a tyrosine kinase family receptor present in mast cell that control cell ...

see more →

News  397 results

Targeted Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria
https://www.medscape.com/viewarticle/980846

Sep 15th, 2022 - MILAN – The therapeutic value of inhibiting the activity of IgE in patients with chronic spontaneous urticaria (CSU) was reinforced by two large phase 3 trials with ligelizumab, a drug characterized as a new generation anti-IgE monoclonal antibody...

Targeted anti-IgE therapy found safe and effective for chronic urticaria
https://www.mdedge.com/dermatology/article/257859/mixed-topics/targeted-anti-ige-therapy-found-safe-and-effective-chronic
Ted Bosworth

Sep 14th, 2022 - MILAN – The therapeutic value of inhibiting the activity of IgE in patients with chronic spontaneous urticaria (CSU) was reinforced by two large phase 3 trials with ligelizumab, a drug characterized as a new generation anti-IgE monoclonal antibody.

Successful Use of Lanadelumab in an Older Patient With Type II Hereditary Angioedema
https://www.mdedge.com/fedprac/article/257745/mixed-topics/successful-use-lanadelumab-older-patient-type-ii-hereditary
Maj Tasha Hellu, DO, Maj Samuel Weiss, MD et. al.

Sep 12th, 2022 - Hereditary angioedema (HAE) is a rare genetic disorder affecting about 1 in 67,000 individuals and may lead to increased morbidity and mortality. 1,2 HAE is characterized by recurring episodes of subcutaneous and/or submucosal edema without urticar.

Study Reviews Adverse Event Reports for Noninvasive Cosmetic Procedures
https://www.medscape.com/viewarticle/979839

Aug 26th, 2022 - Cryolipolysis accounted for a majority of noninvasive cosmetic procedures associated with adverse events, according to an analysis of data from the Manufacturer and User Facility Device Experience (MAUDE). The number of noninvasive body-contouring...

Endo Case Challenge: Rash, Brain Fog, and Sleep Issues in a 50-Year-Old IT Director
https://www.medscape.com/viewarticle/977964

Aug 19th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

see more →

Patient Education  11 results see all →